Table 1.
Demographic and clinical characteristic of patients with acute and recent HIV-1 infection diagnosed between 1995 and 2010.
| Characteristic | Total N=600 | 1995 –1999 N=103 | 2000–2002 N=111 | 2003–2004 N=116 | 2005–2006 N=106 | 2007–2008 N=90 | 2009–N=742010 | P-valuea,b |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| %(N) | %(N) | %(N) | %(N) | %(N) | %(N) | % (N) | ||
| Male sex | 97.7 (542) | 98.9 (87) | 99.0 (97) | 97.2 (105) | 95.2 (98) | 96.5 (83) | 100 (72) | 0.62 |
| Race/Ethnicity | ||||||||
| Non-Hispanic White | 68.0 (379) | 76.1 (67) | 78.6 (77) | 67.6 (73) | 59.2 (61) | 71.3 (62) | 53.4 (39) | |
| Non-Hispanic Black | 7.4 (41) | 8.0 (7) | 6.1 (6) | 5.6 (6) | 5.8 (6) | 8.0(7) | 12.3 (9) | 0.04 |
| Hispanic | 18.0 (100) | 11.4 (10) | 11.2 (11) | 17.6 (19) | 27.2 (28) | 16.1 (14) | 24.7 (18) | |
| Other | 6.6 (37) | 4.6 (4) | 4.0 (4) | 9.3 (10) | 7.8 (8) | 4.6 (4) | 9.6 (7) | |
| US-Born | 75.8 (389) | 82.9 (68) | 73.9 (68) | 76.2 (77) | 69.6 (71) | 79.0 (49) | 75.7 (56) | 0.42 |
| NYC Resident | 80.1 (434) | 63.1 (53) | 84.7 (83) | 79.6 (82) | 83.7 (82) | 79.1 (68) | 90.4 (66) | 0.001 |
| CD4 ≤ 200 | 8.2 (49) | 7.8 (8) | 11.7 (13) | 7.8 (9) | 7.6 (8) | 11.1(10) | 1.4 (1) | 0.21 |
|
| ||||||||
| Mean(±SD) | Mean(±SD) | Mean(±SD) | Mean(±SD) | Mean(±SD) | Mean(±SD) | Mean (±SD) | ||
|
| ||||||||
| Ageb | 35.1 (±8.2) | 34.5 (±7.2) | 35.7 (±6.9) | 35.3 (±7.6) | 34.9 (±8.7) | 34.4 (±8.7) | 35.8 (±10.1) | 0.81 |
| Duration of HIV-1 infection (days) b | 66.6 (52.6) | 58.2 (±35.7) | 46.8 (±41.3) | 66.7 (±62.9) | 80.3 (±67.4) | 83.4 (±42.5) | 66.4 (±38.9) | <0.001 |
| HIV-1 RNA (Log10 copies/mL) b | 5.1 (±1.2) | 5.0 (±1.1) | 5.6 (±1.3) | 5.1 (±1.3) | 5.0 (±1.0) | 4.9 (±1.1) | 4.8 (±1.1) | <0.001 |
| CD4+(cells/mm3) b | 466 (±216) | 500 (±248) | 423 (±221) | 452 (±207) | 442 (±172) | 473 (±214) | 526 (±214) | 0.01 |
a
Chi squared test for linear trend for categorical variable;
b
Analyses of Variance (ANOVA) for linear variables.
Frequencies vary due to missing values.